Your browser doesn't support javascript.
loading
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group.
Michallet, Anne-Sophie; Campidelli, Arnaud; Lequeu, Helene; Dilhuydy, Marie-Sarah; Tournilhac, Olivier; Fornecker, Luc-Matthieu; Dupuis, Jehan; Cymbalista, Florence; De Guibert, Sophie; Delmer, Alain; Vilque, Jean-Pierre; Ghez, David; Leblond, Veronique; Subtil, Fabien; Feugier, Pierre; Ysebaert, Loic.
Afiliação
  • Michallet AS; Department of hematology, Centre Léon Bérard, CLCC, Lyon, France.
  • Campidelli A; Brabois hospital, Department of hematology, CHU Nancy, Vandoeuvre les Nancy, France.
  • Lequeu H; Department of hematology, Hospices Civils de Lyon, Lyon, France.
  • Dilhuydy MS; Haut Levêque hospital, Deaptment of hematology, CHU Bordeaux, Bordeaux, France.
  • Tournilhac O; Estaing hospital, CHU Clermont Ferrand, Clermont Ferrand, France.
  • Fornecker LM; Civil hospital, CHU Strasbourg, Strasbourg, France.
  • Dupuis J; Henri Mondor hospital, lymphoid unit, APHP, Paris, France.
  • Cymbalista F; Avicenne Hospital, APHP, Paris, France.
  • De Guibert S; Department of hematology, CHU Rennes, Rennes, France.
  • Delmer A; Robert Debré hospital, CHU Reims, Reims, France.
  • Vilque JP; Hematology institute Basse Normandie, CHU Caen, Caen, France.
  • Ghez D; Department of hematology, Institut Gustave Roussy, Paris, France.
  • Leblond V; UPMC University Paris 6 GRC11 GRECHY, APHP Hôpital Pitié Salpétrière, Paris, France.
  • Subtil F; Department of biosatistics, Hospices Civils de Lyon, Lyon, France.
  • Feugier P; Brabois hospital, Department of hematology, CHU Nancy, Vandoeuvre les Nancy, France.
  • Ysebaert L; IUCT Oncopole, Toulouse, France.
Am J Hematol ; 92(6): E105-E107, 2017 06.
Article em En | MEDLINE | ID: mdl-28295510
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Leucemia Linfocítica Crônica de Células B / Inibidores de Proteínas Quinases / Terapia de Alvo Molecular / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Leucemia Linfocítica Crônica de Células B / Inibidores de Proteínas Quinases / Terapia de Alvo Molecular / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article